Novel dna aptamer and use thereof
AssigneesJp Bio A Inc., National Cancer Center
InventorsYun Hee KIM, Kyun HEO, Sun II CHOI, In Hoo KIM
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to novel DNA aptamers and use thereof. In particular, the present disclosure relates to DNA aptamers selected from a DNA library using Cell-SELEX to bind specifically to cancer cells. The DNA aptamers of the present disclosure selected and optimized for high binding affinity to cancer cells can be effectively used for the diagnosis of cancer as they have enhanced targeting efficiencies for target cells and tissues as well as high serum stability.
Claims18
A DNA aptamer comprising a nucleotide sequence having at least 90% homology to the nucleotide sequence of SEQ ID NO:
- 6.
Dependencies are inferred from the claim text.